Landos Biopharma Ownership 2024 | Who Owns Landos Biopharma Now?
Institutional Ownership
0.00%
Insider Ownership
9.89%
Retail Ownership
90.11%
Institutional Holders
1.00
Landos Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -12 | -100.00% | - | Jun 30, 2024 |
Landos Biopharma's largest institutional shareholder is CORNERSTONE PLANNING GROUP LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -12 | -100.00% | - | Jun 30, 2024 |
The largest Landos Biopharma shareholder by % of total assets is CORNERSTONE PLANNING GROUP LLC. The company owns 0.00 shares of Landos Biopharma (LABP), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -12 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Landos Biopharma's largest institutional buyer is CORNERSTONE PLANNING GROUP LLC. The company purchased -12.00 stocks of LABP, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -12 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Landos Biopharma's biggest institutional seller is CORNERSTONE PLANNING GROUP LLC. The company sold -12.00 shares of LABP, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -12 | -100.00% | - | Jun 30, 2024 |
Landos Biopharma's largest sold out institutional shareholder by shares sold is CORNERSTONE PLANNING GROUP LLC, sold -12.00 shares, valued at -, as of undefined.
Landos Biopharma Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
DELAWARE GROUP EQUITY FUNDS IV | 0.13% | 147,182 | - | - | Mar 28, 2024 |
BRIDGEWAY FUNDS INC | 0.02% | 39,000 | - | - | Mar 28, 2024 |
DELAWARE GROUP EQUITY FUNDS IV | 0.01% | 14,718 | - | - | Mar 28, 2024 |
JPMORGAN INSURANCE TRUST | 0.00% | 21,810 | - | - | Mar 31, 2023 |
QUANTITATIVE MASTER SERIES LLC | 0.00% | 8,208 | - | - | Mar 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 617 | - | - | Mar 31, 2024 |
BRIDGEWAY FUNDS INC | 0.00% | 2,098 | - | - | Mar 28, 2024 |
Voya INVESTORS TRUST | 0.00% | 36,027 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 88,220 | - | - | Feb 29, 2024 |
SEASONS SERIES TRUST | 0.00% | 9,410 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 10,349 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 6,803 | - | - | Mar 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 515 | - | - | Mar 31, 2024 |
Goldman Sachs ETF Trust | 0.00% | 9,761 | - | - | Feb 29, 2024 |
JPMorgan Trust I | 0.00% | 99,823 | - | - | Jan 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 12,239 | -34 | -0.28% | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 23,995 | - | - | Mar 31, 2024 |
Global X Funds | 0.00% | 1,492 | - | - | Jan 31, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 761 | - | - | Feb 29, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,200 | - | - | Mar 31, 2024 |
NORTHERN FUNDS | 0.00% | 2,159 | - | - | Mar 28, 2024 |
PROSHARES TRUST | 0.00% | 3,386 | - | - | Feb 29, 2024 |
RYDEX SERIES FUNDS | 0.00% | 44 | - | - | Dec 31, 2023 |
FIDELITY SALEM STREET TRUST | 0.00% | 34,798 | - | - | Mar 31, 2024 |
ProFunds | 0.00% | 100 | - | - | Mar 31, 2024 |
ALLSPRING MASTER TRUST | 0.00% | 538 | - | - | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 1,763 | - | - | Jan 31, 2024 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 14,923 | - | - | Feb 29, 2024 |
RYDEX DYNAMIC FUNDS | 0.00% | 25 | - | - | Dec 31, 2023 |
VALIC Co I | 0.00% | 1,735 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 2,399 | -2,399 | -50.00% | Mar 31, 2024 |
RYDEX VARIABLE TRUST | 0.00% | 6 | - | - | Dec 31, 2023 |
Guggenheim Active Allocation Fund | 0.00% | 28 | - | - | Feb 29, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 607 | - | - | Jan 31, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 611 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 4,000 | 4,000 | - | Mar 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 200 | - | - | Mar 31, 2023 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 3,166 | - | - | Mar 31, 2024 |
Invesco Exchange-Traded Fund Trust II | 0.00% | 746 | - | - | Jan 31, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 246 | - | - | Feb 29, 2024 |
iSHARES TRUST | 0.00% | 32,394 | - | - | Mar 31, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 4,200 | - | - | Mar 31, 2024 |
ETF Series Solutions | 0.00% | 32 | - | - | Jan 31, 2024 |
TIAA-CREF FUNDS | 0.00% | 4,325 | - | - | Mar 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 516 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,001 | - | - | Mar 31, 2024 |
PACIFIC SELECT FUND | 0.00% | 2,105 | - | - | Mar 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 475 | - | - | Dec 31, 2023 |
Guggenheim Active Allocation Fund | 0.00% | 2 | - | - | Feb 29, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 639 | - | - | Mar 31, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 763 | - | - | Mar 31, 2024 |
Bridge Builder Trust | 0.00% | 720 | - | - | Mar 31, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 935 | - | - | Feb 29, 2024 |
Landos Biopharma's largest mutual fund holder by % of total assets is "DELAWARE GROUP EQUITY FUNDS IV", owning 147.18K shares, compromising 0.13% of its total assets.
Landos Biopharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 1 | - |
31 Dec, 23 | 1 | - |
31 Mar, 23 | 17 | -15.00% |
31 Dec, 22 | 20 | -23.08% |
30 Sep, 22 | 26 | -18.75% |
30 Jun, 22 | 32 | -25.58% |
31 Mar, 22 | 43 | 10.26% |
31 Dec, 21 | 39 | 11.43% |
30 Sep, 21 | 35 | 9.38% |
30 Jun, 21 | 32 | -31.91% |
31 Mar, 21 | 47 | 4600.00% |
31 Dec, 20 | 1 | - |
As of 31 Mar 24, 1 institutions are holding Landos Biopharma's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 12 | - |
31 Dec, 23 | 12 | - |
31 Mar, 23 | 15,534,308 | -1.34% |
31 Dec, 22 | 15,744,848 | -27.12% |
30 Sep, 22 | 21,603,076 | -3.84% |
30 Jun, 22 | 22,466,549 | -6.02% |
31 Mar, 22 | 23,904,524 | -4.19% |
31 Dec, 21 | 24,949,116 | 10.03% |
30 Sep, 21 | 22,674,777 | -0.17% |
30 Jun, 21 | 22,713,718 | -2.32% |
31 Mar, 21 | 23,253,704 | 23253604.00% |
31 Dec, 20 | 100 | - |
Landos Biopharma (LABP) has 12.00 shares outstanding as of 31 Mar 24, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 0.00% | 494550.00% |
31 Dec, 23 | 0.00% | - |
31 Mar, 23 | 2.40% | 15.66% |
31 Dec, 22 | 3.91% | 13.58% |
30 Sep, 22 | 5.37% | 17.23% |
30 Jun, 22 | 5.58% | 15.83% |
31 Mar, 22 | 5.94% | 13.46% |
31 Dec, 21 | 6.64% | 20.63% |
30 Sep, 21 | 5.67% | 12.45% |
30 Jun, 21 | 6.75% | 8.49% |
31 Mar, 21 | 8.92% | - |
31 Dec, 20 | - | - |
As of 31 Mar 24, Landos Biopharma is held by 0.00% institutional shareholders, representing a 494550.00% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | - | -100.00% |
31 Dec, 23 | 1 | - |
31 Mar, 23 | 7 | -22.22% |
31 Dec, 22 | 9 | 12.50% |
30 Sep, 22 | 8 | -42.86% |
30 Jun, 22 | 14 | -30.00% |
31 Mar, 22 | 20 | -9.09% |
31 Dec, 21 | 22 | 46.67% |
30 Sep, 21 | 15 | 36.36% |
30 Jun, 21 | 11 | -76.09% |
31 Mar, 21 | 46 | 4500.00% |
31 Dec, 20 | 1 | - |
- institutional shareholders have increased their position in LABP stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | - | - |
31 Dec, 23 | - | - |
31 Mar, 23 | 6 | 20.00% |
31 Dec, 22 | 5 | -44.44% |
30 Sep, 22 | 9 | -30.77% |
30 Jun, 22 | 13 | 8.33% |
31 Mar, 22 | 12 | 71.43% |
31 Dec, 21 | 7 | -53.33% |
30 Sep, 21 | 15 | 66.67% |
30 Jun, 21 | 9 | - |
31 Mar, 21 | - | - |
31 Dec, 20 | - | - |
- institutional shareholders have reduced their position in LABP stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 1 | - | 12 | - | 0.00% | 494550.00% | - | -100.00% | - | - |
31 Dec, 23 | 1 | - | 12 | - | 0.00% | - | 1 | - | - | - |
31 Mar, 23 | 17 | -15.00% | 15,534,308 | -1.34% | 2.40% | 15.66% | 7 | -22.22% | 6 | 20.00% |
31 Dec, 22 | 20 | -23.08% | 15,744,848 | -27.12% | 3.91% | 13.58% | 9 | 12.50% | 5 | -44.44% |
30 Sep, 22 | 26 | -18.75% | 21,603,076 | -3.84% | 5.37% | 17.23% | 8 | -42.86% | 9 | -30.77% |
30 Jun, 22 | 32 | -25.58% | 22,466,549 | -6.02% | 5.58% | 15.83% | 14 | -30.00% | 13 | 8.33% |
31 Mar, 22 | 43 | 10.26% | 23,904,524 | -4.19% | 5.94% | 13.46% | 20 | -9.09% | 12 | 71.43% |
31 Dec, 21 | 39 | 11.43% | 24,949,116 | 10.03% | 6.64% | 20.63% | 22 | 46.67% | 7 | -53.33% |
30 Sep, 21 | 35 | 9.38% | 22,674,777 | -0.17% | 5.67% | 12.45% | 15 | 36.36% | 15 | 66.67% |
30 Jun, 21 | 32 | -31.91% | 22,713,718 | -2.32% | 6.75% | 8.49% | 11 | -76.09% | 9 | - |
31 Mar, 21 | 47 | 4600.00% | 23,253,704 | 23253604.00% | 8.92% | - | 46 | 4500.00% | - | - |
31 Dec, 20 | 1 | - | 100 | - | - | - | 1 | - | - | - |
Landos Biopharma Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Landos Biopharma's stock was made by MAYLEBEN TIMOTHY M on May 23 2024, selling 1,800 shares at $7.90 per share (valued at $14.22K).
Landos Biopharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | 21 | - |
Q1 2024 | 2 | - | - |
Q2 2023 | 6 | - | - |
Q1 2023 | 9 | 1 | 900.00% |
Q4 2022 | - | - | - |
Q3 2022 | 2 | 1 | 200.00% |
Q2 2022 | 12 | 1 | 1200.00% |
Q1 2022 | 1 | 1 | 100.00% |
Q4 2021 | 2 | 20 | 10.00% |
Q3 2021 | 4 | 2 | 200.00% |
Q2 2021 | 2 | - | - |
Q1 2021 | 22 | 8 | 275.00% |
0 total buy trades, and 21 total sell trades (buy/sell ratio of 0.00%) were made by Landos Biopharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q2 2023 | - | - | - |
Q1 2023 | 4 | 1 | 400.00% |
Q4 2022 | - | - | - |
Q3 2022 | - | 1 | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | 16 | - |
Q3 2021 | - | - | - |
Q2 2021 | - | - | - |
Q1 2021 | 15 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Landos Biopharma's stocks.
LABP Ownership FAQ
Who Owns Landos Biopharma?
Landos Biopharma is owned by institutional shareholders (0.00%), insiders (9.89%), and public (90.11%). The largest institutional shareholder of Landos Biopharma is CORNERSTONE PLANNING GROUP LLC (0% of total shares) and the top mutual fund owner is DELAWARE GROUP EQUITY FUNDS IV (0.13% of total shares).
Who are the major institutional shareholders of Landos Biopharma?
Landos Biopharma's major institutional shareholders are CORNERSTONE PLANNING GROUP LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Landos Biopharma shareholders are there?
As of Mar 2024, there are 1 institutional shareholders of Landos Biopharma.
What percentage of Landos Biopharma is owned by CORNERSTONE PLANNING GROUP LLC?
CORNERSTONE PLANNING GROUP LLC owns 0 shares of Landos Biopharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).